Latanoprost 0.005% Ophthalmic Solution (XALATAN)

DRUG3 trials

Sponsors

Alcon Research

Conditions

GlaucomaOcular HypertensionOpen-Angle GlaucomaOpen-angle Glaucoma

Phase 3

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

CompletedNCT00293787

Alcon ResearchOcular Hypertension, Open-angle Glaucoma

Start: 2004-06-30End: 2005-08-31Updated: 2012-02-14

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

CompletedNCT00293800

Alcon ResearchOcular Hypertension, Open-Angle Glaucoma

Start: 2004-07-31End: 2005-12-31Updated: 2012-02-14

Phase 4

A Comparison of Azopt Versus Placebo Added to Xalatan in Patients With Elevated Intraocular Pressure (IOP) on a Prostaglandin

CompletedNCT00759941

Alcon ResearchGlaucoma

Start: 2007-10-31End: 2009-07-31Updated: 2014-01-13